New treatment options in childhood constipation?

Journal of Pediatric Gastroenterology and Nutrition

Volumn 41, Issue SUPPL. 1, 2005, Pages

  Benninga, Marc A ^a   Candy, David C A ^b   Taminiau, Jan A ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b Worthing Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LAXATIVE; PREBIOTIC AGENT; PROBIOTIC AGENT; TEGASEROD;

ABDOMINAL PAIN; BEHAVIOR THERAPY; CHILD; CHILD REARING; CHILDHOOD DISEASE; CONFERENCE PAPER; CONSTIPATION; FLUID INTAKE; HEADACHE; HIGH FIBER DIET; HUMAN; INTESTINE TRANSIT TIME; PRIORITY JOURNAL;

ABDOMINAL PAIN; BEHAVIOR THERAPY; CATHARTICS; CHILD; CONSTIPATION; HUMANS; PATIENT EDUCATION; POLYETHYLENE GLYCOLS; PROBIOTICS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS;

EID: 24744434897     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.scs.0000180307.02052.56     Document Type: Conference Paper

References (12)

1. van Ginkel R, Reitsma JB, Büller HA, et al. Childhood constipation: Longitudinal follow-up beyond puberty. Gastroenterology 2003;125:357-63.
2. Baker SS, Liptak GS, Colletti RB, et al. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1999;29:612-26.
3. Johanson JF, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004;2:796-805.
4. Kamm MA, Muller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 2005;100:362-72.
5. Moore N, Chao C, Yang LP, et al. Effects of fructo-oligosaccharide- supplemented infant cereal: a double-blind, randomized trial. Br J Nutr 2003;90:581-7.
6. Marteau P, Cuillerier E, Meance S, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind randomized, controlled study. Aliment Pharmacol Ther 2002;16:587-93.
7. Banaszkiewicz A, Szajewska H. Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. J Pediatr 2005;146:364-9.
8. Backhed F, Ley RE, Sonnenburg JL, et al. Host bacterial Mutualism in the Human Intestine. Science 2005;307:1915-9.
9. Jarrett ME, Mowatt G, Glazener CM, et al. Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg 2004;91:1559-69.
10. Loening-Baucke V, Krishna R, Pashankar DS. Polyethylene glycol 3350 without electrolytes for the treatment of functional constipation in infants and toddlers. J Pediatr Gastroenterol Nutr 2004;39:536-9.
11. Voskuijl W, de Lorijn F, Verwijs W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut 2004;53:1590-4.
12. Youssef NN, Peters JM, Henderson W, et al. Dose response of PEG 3350 for the treatment of childhood fecal impaction. J Pediatr 2002;141:410-4.